Ad
related to: worldwide clinical trials address
Search results
IBC Addresses Critical Supply Shortages of Ac-225 with Commercially Available Molecular Recognition...
The Herald Journal· 1 day agoStrong clinical potential of radioligand therapy is evident from recently published clinical trial resultsGlobal supply shortage of Ac ...
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Valley City Times Record· 6 days agoThe company will showcase the latest clinical trial findings for IMC001 in a poster presentation and...
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of...
Morningstar· 3 days ago(NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments ...
Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at...
Benzinga· 1 day agoOcuphire Pharma, Inc. OCUP ("Ocuphire"), a clinical-stage biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal ...
Breakthroughs in Breast Cancer: Susan G. Komen(R) | Newswise
Newswise· 2 days agoScholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization, showcased cutting-edge breast cancer research aimed at advancing the field at the ASCO Annual ...
Master’s Degree In Psychedelics Studies Debuts At University Of Ottawa
Forbes· 14 hours agoAchieving a master’s degree with a focus on psychedelics and consciousness itself is now a reality,...
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have...
Morningstar· 4 days agoIn a clinical trial involving 30 adult patients, three groups received the same dose of the drug but with different regimens over a period of 12 months.
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
The Woonsocket Call· 6 days agoEMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and ...
Common heart problem ‘carries higher stroke and dementia risk than expected’
PA Media: Science via Yahoo News· 2 days ago“With its prevalence continuing to rise, it is crucial that we develop strategies...big concern for...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 6 days agoXtalks Announces its Life Science Webinar Calendar for June 2024 PR Newswire TORONTO, June 1, 2024 Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and ...
